The tumor-associated antigens (TAAs) including CEA, NSE, CA125, SCC, CA15-3, pro-GRP, and CYFRA21-1 are widely used blood-based biomarkers that help to diagnose lung cancer. This evidence concerns the gene ENO2 and lung cancer.